Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 73.72B | 72.77B | 69.89B | 62.51B | 50.23B | 44.12B |
Gross Profit | 13.13B | 42.34B | 9.65B | 8.05B | 6.81B | 4.84B |
EBITDA | 12.06B | 12.78B | 11.81B | 10.54B | 7.72B | 5.88B |
Net Income | 4.76B | 4.86B | 4.70B | 4.26B | 2.60B | 1.24B |
Balance Sheet | ||||||
Total Assets | 130.44B | 129.49B | 118.56B | 111.99B | 100.82B | 91.17B |
Cash, Cash Equivalents and Short-Term Investments | 16.18B | 16.17B | 16.17B | 13.33B | 11.27B | 11.90B |
Total Debt | 42.62B | 36.26B | 31.42B | 31.02B | 32.84B | 32.50B |
Total Liabilities | 98.03B | 95.46B | 86.52B | 82.58B | 76.05B | 67.99B |
Stockholders Equity | 28.61B | 29.95B | 28.11B | 25.94B | 22.88B | 21.01B |
Cash Flow | ||||||
Free Cash Flow | 8.44B | 7.66B | 7.21B | 5.89B | 5.74B | 4.51B |
Operating Cash Flow | 11.24B | 11.71B | 10.54B | 9.39B | 7.81B | 6.67B |
Investing Cash Flow | -5.64B | -9.05B | -3.98B | -5.30B | -5.80B | -2.57B |
Financing Cash Flow | -3.07B | -3.03B | -3.43B | -2.78B | -3.26B | -42.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | 10.81B | 10.74 | 15.49% | 4.21% | 7.71% | -2.82% | |
73 Outperform | €65.71B | 13.93 | 16.66% | 4.04% | 3.21% | 4.24% | |
70 Outperform | 8.02B | 39.50 | 13.15% | 2.20% | 10.87% | -10.35% | |
68 Neutral | 14.26B | 13.42 | 8.66% | 5.35% | 1.26% | 4.64% | |
65 Neutral | 10.24B | -0.83 | 2.48% | 6.22% | 8.44% | -937.75% | |
56 Neutral | 651.00M | 81.12 | 2.78% | 2.28% | 6.72% | -90.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |